Products for Research Use Only
RegisterLogin

Tarlox-TKI

CAT: 0931-T11761-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T11761-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2135696-72-7
Target
EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.9703
Bioactivity
Tarlox-TKI (Kinase inhibitor-1) is a pan-ErbB inhibitor, the active ingredient of Tarloxotinib, with antitumor activity.Tarlox-TKI inhibits NRG1 and suppresses HER2 mutants.
Smiles
CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1
Molecular Formula
C19H18BrClN6O
Molecular Weight
461.74
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
TP2958-01Tkip
T8700-01TKIM
T207634-01TarO-IN-1

Alternative Products

CatalogName
HY-43533-01Tarlox-TKI
C07439-01Dovitinib (TKI-258)
A11411-200Dovitinib (TKI-258) 200mg
A11411-5Dovitinib (TKI-258) 5mg
A11411-500Dovitinib (TKI-258) 500mg
A2168-25Dovitinib (TKI-258, CHIR-258)
MBS578758Dovitinib (TKI-258) Dilactic Acid
A11411-10mM-DDovitinib (TKI-258) 10mM * 1mL in DMSO
D9060Dovitinib, Free Base (4-Amino-5-fluoro-3-[6- (4-methyl-1-piperazinyl) -1H-benzimidazol-2-yl]-2 (1H) -quinolinone) (CHIR-258, TKI-258)
MBS655420-01Dovitinib, Free Base (4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone) (CHIR-258, TKI-258)

Popular Products